Abstract

BackgroundTick control is an essential aspect of controlling the spread of tick-borne diseases affecting humans and animals, but it presently faces several challenges. Development of an anti-tick vaccine is aimed at designing cost-effective and environmentally friendly protection against ticks and tick-borne diseases as an alternative to the use of chemical acaricides. A single vaccine from the tick midgut protein Bm86 is currently available for field applications, but its efficacy is limited to only some tick species. Identification of candidate vaccine antigens that can affect multiple tick species is highly desirable. The hard tick Haemaphysalis longicornis has two kinds of the iron-binding protein ferritin (HlFER), an intracellular HlFER1 and a secretory HlFER2, and RNA interference experiments showed that these are physiologically important in blood feeding and reproduction and in protection against oxidative stress. Here we investigated the potential of targeting HlFERs for tick control by immunizing the host with recombinant HlFERs (rHlFER1 and rHlFER2).MethodsRabbits were immunized with rHlFERs three times subcutaneously at two-week intervals. Antisera were collected before the first immunization and a week after each immunization to confirm the antigen-specific serum antibody titer by serum ELISA. Two weeks after the final immunization, the rabbits were challenged with tick infestation. After dropping, tick feeding and reproduction parameters were evaluated to determine vaccine efficacy. To demonstrate the effects of antibodies, oxidative stress was detected in the eggs and larvae.ResultsThe antibody titer of rHlFER-immunized rabbits greatly increased after the second immunization. Antibodies exhibited cross-reactivity with rHlFERs and reacted with tick native HlFERs in Western blot analysis. Significantly lower bodyweight was observed in the ticks infested from the rHlFER2-immunized rabbit compared to those from the control rabbit. Reduced oviposition and hatching rate were observed in both rHlFER-immunized groups. rHlFER2 showed a higher vaccine efficacy. The antibodies against rHlFERs were detected in the eggs, and higher levels of oxidative stress biomarkers in the eggs and larvae, of ticks from rHlFER vaccinated rabbits.ConclusionCollectively, these results showed that HlFER2 has a good potential as an anti-tick vaccine antigen that may affect multiple tick species.Electronic supplementary materialThe online version of this article (doi:10.1186/s13071-014-0482-x) contains supplementary material, which is available to authorized users.

Highlights

  • Tick control is an essential aspect of controlling the spread of tick-borne diseases affecting humans and animals, but it presently faces several challenges

  • Whereas no changes were observed in the antibody titers of the control group, the antibody titers of the groups immunized against recombinant HlFER1 (rHlFER1) (Figure 2A) and recombinant HlFER2 (rHlFER2) (Figure 2B) significantly increased after the second immunization

  • The antibodies exhibited cross-reactivity to each antigen. rHlFER1immunized rabbits showed an abrupt increase in antibody titer against rHlFER1 after the second immunization, which further increased after the third immunization, while the titer for rHlFER2 only significantly increased after the third immunization

Read more

Summary

Introduction

Tick control is an essential aspect of controlling the spread of tick-borne diseases affecting humans and animals, but it presently faces several challenges. Ticks and tick-borne diseases remain threats to human and animal health worldwide. Lyme borreliosis and tick-borne encephalitis are among the most important diseases transmitted by ticks [1]. The hard tick Haemaphysalis longicornis, mainly distributed in East Asia and Australia, is a known vector of babesiosis caused by Babesia ovata, B. major, B. gibsoni, and possibly B. bigemina and of theileriosis caused by Theileria sergenti, T. orientalis, and T. buffeli [3,4]. H. longicornis has been strongly implicated as a vector of severe fever with thrombocytopenia syndrome (SFTS) virus affecting humans, which has been reported in China [5], Japan [6] and South Korea [7]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.